We are live on ! Find out more
CXAC.WS

C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS

Delisted

CXAC.WS was delisted on the 11th of October, 2023.

40 hedge funds and large institutions have $9.39M invested in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

33% more funds holding

Funds holding: 3040 (+10)

8% more capital invested

Capital invested by funds: $8.66M → $9.39M (+$724K)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
40
Holders Change
+10
Holders Change %
+33.33%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
3
Reduced
5
Closed
4
Calls
$1.58M
Puts
Net Calls
+$1.58M
Net Calls Change
-$12K

CXAC.WS Hedge Fund Activity: Q2 2022 in Review

40 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) for Q2 2022, worth a combined $9.39M — up 8.4% from $8.66M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CXAC.WS positions and 4 closed out — a net gain of 10 holders — while 3 added to existing stakes and 5 trimmed.

The largest buyer was Parallax Volatility Advisers, adding an estimated $200K. The largest seller was Zazove Associates, exiting entirely with an estimated $39K sold.

  • 40 institutional investors held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) as of Q2 2022, up from 30 in Q1 2022.
  • Funds reported $9.39M of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share stock for Q2 2022, up 8.4% quarter-over-quarter.
  • 14 funds opened new C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share positions in Q2 2022 and 4 closed out, a net change of +10 holders.
  • The largest C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share buyer in Q2 2022 was Parallax Volatility Advisers, an estimated $200K added.
  • The largest C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share seller in Q2 2022 was Zazove Associates, an estimated $39K sold.

Based on aggregated 13F filings for Q2 2022.